# Detection of cytogenetic abnormalities in multiple myeloma by using optical genome mapping

## TL;DR

This paper explores using optical genome mapping to detect chromosomal abnormalities in multiple myeloma patients.

## Contribution

The study is the first to apply optical genome mapping (OGM) for detecting cytogenetic abnormalities in multiple myeloma.

## Key findings

- OGM successfully detected chromosomal abnormalities in five newly diagnosed multiple myeloma patients.
- The results were compared with traditional cytogenetic methods to evaluate OGM's effectiveness.
- OGM shows potential as a clinical tool for chromosomal analysis in multiple myeloma.

## Abstract

多发性骨髓瘤（MM）是一种以单克隆浆细胞在骨髓中异常增殖为特征的血液肿瘤，MM细胞具有复杂的染色体数目异常和结构异常，这些异常对于患者的危险度分层以及疗效评估具有重要的意义。全基因组光学图谱（OGM）是一项新型的细胞遗传学检测技术，目前在肿瘤、辅助生殖、发育异常等领域已经显示出一定的应用前景，本研究首次利用OGM技术对5例新发MM患者的细胞遗传学异常进行检测，并将其与传统细胞遗传学检测技术进行了比较，从而评估该技术对染色体异常的检出能力以及在MM中的临床应用价值。